FIELD: medicine, pharmacology.
SUBSTANCE: invention relates to methods and compositions, which can be used for prevention and treatment of infections caused by hepatitis C virus (HCV). The DNA vaccines, which contain polynucleotide sequences coding HCV proteins, the method of prevention and treatment of HCV infection, the method of subject's vaccination, as well as the application of the above mentioned vaccine for manufacturing medicine, are proposed.
EFFECT: invention can be used to treat and prevent viral infection.
24 cl, 24 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINE | 2003 |
|
RU2363492C2 |
| COMPOSITIONS CONTAINING CATION MICROPARTICLES AND DNA HCV E1E2, AND METHODS OF THEIR APPLICATION | 2004 |
|
RU2364419C2 |
| METHOD FOR DETERMINING HCV-ANTIGEN/ANTIBODY COMPLEX | 2001 |
|
RU2274863C2 |
| COMPOSITION FOR IMMUNE RESPONSE STIMULATION (VARIANTS), METHODS FOR PRODUCTION AND USING THEREOF AND METHOD FOR IMMUNE RESPONSE STIMULATION USING THE SAME | 2002 |
|
RU2316347C2 |
| BIOMARKER FOR PATIENT'S MONITORING | 2010 |
|
RU2542435C2 |
| BIOMARKER FOR SELECTING PATIENTS AND RESPECTIVE QUESTIONS | 2009 |
|
RU2517719C2 |
| BIOMARKER FOR PATIENT MONITORING | 2010 |
|
RU2555340C2 |
| IMMUNOBIOLOGICAL AGENT TO ENHANCE CELLULAR RESPONSE AGAINST HEPATITIS C VIRUS | 2023 |
|
RU2811136C1 |
| OLIGOMERIC PARTICLE INDUCING IMMUNITY AGAINST HEPATITIS C VIRUS, METHOD FOR PREPARING OLIGOMERIC PARTICLE, COMPOSITION, SPECIFIC ANTIBODY, SET (VARIANTS), IMMUNOLOGICAL ANALYSIS AND VACCINE AGAINST HEPATITIS C VIRUS | 1999 |
|
RU2247729C2 |
| POLYPEPTIDE AND METHOD OF ITS SYNTHESIS, REAGENT FOR IMMUNO-ANALYSIS, METHOD OF ASSAY OF ANTIBODY PRESENCE, METHOD OF INDUCTION OF IMMUNE RESPONSE | 1992 |
|
RU2148587C1 |
